BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24218177)

  • 1. Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats.
    Villa-Mancera A; Reynoso-Palomar A; Utrera-Quintana F; Carreón-Luna L
    Parasitol Res; 2014 Jan; 113(1):243-50. PubMed ID: 24218177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
    Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
    Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep.
    Villa-Mancera A; Méndez-Mendoza M
    Vet J; 2012 Oct; 194(1):108-12. PubMed ID: 22513301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
    Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
    Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
    Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
    Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures.
    Villa-Mancera A; Alcalá-Canto Y; Olivares-Pérez J; Molina-Mendoza P; Hernández-Guzmán K; Utrera-Quintana F; Carreón-Luna L; Olmedo-Juárez A; Reynoso-Palomar A
    Microb Pathog; 2021 Jun; 155():104859. PubMed ID: 33845124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library.
    Villa-Mancera A; Quiroz-Romero H; Correa D; Ibarra F; Reyes-Pérez M; Reyes-Vivas H; López-Velázquez G; Gazarian K; Gazarian T; Alonso RA
    Parasitology; 2008 Oct; 135(12):1437-45. PubMed ID: 18812010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica.
    Zafra R; Pérez-Écija RA; Buffoni L; Moreno P; Bautista MJ; Martínez-Moreno A; Mulcahy G; Dalton JP; Pérez J
    J Comp Pathol; 2013 May; 148(4):373-84. PubMed ID: 23083835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
    Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
    J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica.
    Pérez-Ecija RA; Mendes RE; Zafra R; Buffonni L; Martínez-Moreno A; Pérez J
    Vet J; 2010 Sep; 185(3):351-3. PubMed ID: 19665401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of sheep with Quil-A® adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes.
    Orbegozo-Medina RA; Martínez-Sernández V; González-Warleta M; Castro-Hermida JA; Mezo M; Ubeira FM
    Vaccine; 2018 Apr; 36(15):1949-1957. PubMed ID: 29525280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hepatic and peritoneal changes and immune response in goats vaccinated with a recombinant glutathione transferase sigma class and challenged with Fasciola hepatica.
    Zafra R; Pérez-Écija RA; Buffoni L; Pacheco IL; Martínez-Moreno A; LaCourse EJ; Perally S; Brophy PM; Pérez J
    Res Vet Sci; 2013 Jun; 94(3):602-9. PubMed ID: 23261152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica.
    Mendes RE; Pérez-Ecija RA; Zafra R; Buffoni L; Martínez-Moreno A; Dalton JP; Mulcahy G; Pérez J
    Vaccine; 2010 Apr; 28(16):2832-40. PubMed ID: 20153792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica.
    Buffoni L; Martínez-Moreno FJ; Zafra R; Mendes RE; Pérez-Écija A; Sekiya M; Mulcahy G; Pérez J; Martínez-Moreno A
    Vet Parasitol; 2012 Apr; 185(2-4):315-21. PubMed ID: 22001704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection.
    De Bont J; Claerebout E; Riveau G; Schacht AM; Smets K; Conder G; Brake DA; Capron A; Vercruysse J
    Vet Parasitol; 2003 Apr; 113(2):135-44. PubMed ID: 12695038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
    Mendes RE; Zafra R; Pérez-Ecija RA; Buffoni L; Martínez-Moreno A; Tendler M; Pérez J
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):698-705. PubMed ID: 20835620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica.
    Pacheco IL; Abril N; Morales-Prieto N; Bautista MJ; Zafra R; Escamilla A; Ruiz MT; Martínez-Moreno A; Pérez J
    Vet Parasitol; 2017 Apr; 238():61-65. PubMed ID: 28385539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.